Director's Cut

Director's message

“Progress is not achieved by luck or accident, but by working daily”—Epictetus. Well, considering we are in a “growth phase,” this quote certainly holds true to our daily progress. I’m excited to see all the newness with our cancer center growth.

September is Gynecologic Cancer Awareness Month

September marks Gynecologic Cancer Awareness Month, a time to highlight the importance of early detection and prevention. Dr. Mildred Ridgway discusses recommendations.

Dr. Ajay Singh named professor in cell & molecular biology and associate director of basic and translational research

Dr. Ajay Singh is a new professor in the Department of Cell & Molecular Biology and the associate director of basic and translational research for the Cancer Center and Research Institute (CCRI). Singh will be responsible for strategic planning and operations to drive growth and enhance the CCRI's research mission while ensuring alignment with its clinical objectives.

Dr. Rojymon Jacob named chair of radiation oncology

Dr. Rojymon Jacob is the new chair of Radiation Oncology in the School of Medicine. In this role, he will lead both clinical care and research initiatives, oversee the modernization of practices, establish quality standards, and enhance the training of radiation oncology residents.

Rebecca Pope takes on new role as interdepartmental team coordinator in surgical specialty clinic

A seasoned professional nurse, Pope has a diverse and dynamic career spanning over three decades. Her recent role as a travel nurse, where she worked at various hospitals across the country, highlights her broad clinical expertise.

Dr. Jasmine Miller-Kleinhenz receives NIH grant to explore racial disparities in aggressive breast cancer

Dr. Jasmine Miller-Kleinhenz, assistant professor in the John D. Bower School of Population Health, was recently awarded an NCI R00 grant to fund research aimed at exploring the complex relationship between socio-structural factors and tumor biology in the case of triple negative breast cancer (TNBC). The grant, titled “Investigating Socio-Structural Determinants of Health and the Tumor Epigenome to Understand the Etiology of Racial Disparities in Breast Cancer,” will support Miller-Kleinhenz’s effort to address one of the most critical concerns in cancer health disparities.

Recent publications

Breast cancer is the most frequently diagnosed cancer and the second leading cause of cancer-related deaths among women in the US. Additionally, it shows notable racial disparities in health outcomes.

PR pulse monthly insights

PR Pulse is your monthly source for the cancer institute's social media presence. For the latest news and updates on the CCRI, please follow us on Facebook and X. Stay connected and engaged with our latest initiatives and developments!

September 2024